Insider Purchase: Director at $MTH Buys 4,000 Shares

Director Joseph Keough purchased 4,000 shares of $MTH on June 12, 2025, for approximately $264,640, increasing their holdings by 10.6% to 41,700 shares; this is one of two insider buys in the last six months, versus five sales. Institutional investors showed mixed activity in Q1 2025, with Long Pond Capital increasing its position by 246.3% while GRS Advisors decreased theirs by 96.0%. Recent analyst price targets for $MTH average $105.

Analysis

Recent insider activity at Meritage Homes Corporation ($MTH) includes a notable purchase by director Joseph Keough, who acquired 4,000 shares on June 12, 2025, for approximately $264,640, thereby increasing his stake by 10.6% to 41,700 shares. This transaction, occurring at an implied price of roughly $66.16 per share, is one of two insider purchases in the last six months, contrasted with five sales during the same period. Notably, Executive Chairman Steven J Hilton executed offsetting purchase and sale transactions of 11,000 shares each. Institutional holdings in Q1 2025 presented a mixed picture: 193 institutions added to their $MTH positions while 160 reduced theirs. Significant increases included Long Pond Capital adding 800,881 shares (+246.3%) and Dendur Capital LP initiating a substantial position with 563,500 shares. Conversely, GRS Advisors, LLC and AllianceBernstein L.P. significantly decreased their holdings by 96.0% and 87.3% respectively. Analyst sentiment, based on two price targets issued in the last six months, is moderately positive, with a median target of $105.0; UBS set a target of $107.0 in April 2025, and Wedbush set $103.0 in January 2025. The overall sentiment signal is neutral, though slightly positive for $MTH specifically, reflecting these somewhat divergent data points.

Key Decisions for Investors

• Investors should note the recent director-level share purchase as a potentially positive signal, especially given the 10.6% increase in holdings, but weigh it against the higher number of insider sales over the past six months.
• The significant divergence in Q1 2025 institutional activity, with major funds both substantially increasing and decreasing positions, warrants careful consideration of individual fund theses and warrants further monitoring of Q2 institutional flows.
• Consider the current implied purchase price of $66.16 by the director in relation to the median analyst price target of $105, which suggests potential upside if analyst outlooks materialize.
• Monitor upcoming SEC filings for further insider transactions to see if Keough's purchase signals a broader shift in insider sentiment or remains an isolated event.